Show Notes
Today, we are talking about a very popular, yet controversial class of medications - the Benzodiazepines . Let's look at their mechanism of action, clinical indications, pharmacology, risks, withdrawal syndromes, and prescribing guidance. And of course, we'll be tackling the question: what are the risks and benefits of long-term use?
References: https://pubmed.ncbi.nlm.nih.gov/30098211/
https://pubmed.ncbi.nlm.nih.gov/32252539/
https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates
https://aapp.org/guideline/benzo
https://pubmed.ncbi.nlm.nih.gov/40526204/
https://pmc.ncbi.nlm.nih.gov/articles/PMC6097846/
More from PsychRounds: The Psychiatry Podcast
Today, we're covering the recent FDA approval of a new Olanzapine long-acting injectable - Weltruza.
Welcome back, everyone! We’re back after PRITE, and today we’re discussing pharmacogenetic testing.
Today, we will discuss GLP-1's and the emerging use of this class of medications in psychiatry.
We resume our landmark studies series looking at the pivotal study in Major Depressive Disorder (MDD), The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) trial.
We have a special guest today to talk about one of our favorite topics... dogs! Most people might intuitively say that they feel like their dogs improve their mental health, but today, we look at the science with the leading expert on the subject.